Accelerate licensing & partnership decisions

Make in-licensing decisions more efficiently and move faster on the right programs

Request a demo

Identify, track, and triage the best drug programs

95% of deals do not pass due diligence processes and simply time, effort, and resources. Efficiently sift through hundreds of opportunities with VibeOne and focus on only those that truly align with your strategy. No model training required.

Speed

8x faster asset diligence with curated, aggregated, & centralized data

Process Flow

Track

Follow catalysts across hundreds of assets easily

Trust

Transparent, explainable scoring with citations to make data-backed decisions

Global

50% more assets identified worldwide, including China, Korea, & Japan

PTRS Analysis Product screenshot.

Purpose-built AI suite for search & eval

  • Scan landscapes and your funnel for high potential programs
  • Identify strategic fits aligned with your scientific, financial, and commercial goals
  • Track competitive markets, assets, and your opportunity in real-time
  • Create custom evaluations against your internal profile
  • Quickly perform deep diligence and risk scoring against biology, CMC, clinical, and regulatory criteria

Accelerate search & evaluation

Save time and money while streamlining due diligence with VibeOne.

Challenges vs. advantages: How VibeOne delivers

Challenge

  • Volume overload: Hundreds of early-stage opportunities
  • Resource bottlenecks: Low-value assets waste time and energy
  • Biased decision-making: Familiarity and recency biases result in poor decisions
  • Language & regional barriers: Lack of in-house foreign language skills results in missed opportunities

VibeOne advantages

  • Conduct asset diligence 8x faster: Use AI-powered to focus research efforts instead of brute-force screening
  • Reduce CME workloads by 75%: Eliminate poor fits early and explore only assets with the best fit and potential
  • Identify 50% more assets: Conduct consistent evaluation across all programs and indications to find more assets, faster
  • Evaluate 40+ languages: Automatically translate and contextualize data from biopharmas around the world

Uncover new possibilities with VibeOne

Learn how VibeOne evaluates and compares drug assets, helping you identify high potential development opportunities more quickly.

Request demo